RCM
ORIC icon

RA Capital Management’s Oric Pharmaceuticals ORIC Stock Holding History

RA Capital Management’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-584,000
Closed -$10.3M – 104
2021
Q2 		$10.3M Hold
584,000
– – 0.17% 74
2021
Q1 		$14.3M Hold
584,000
– – 0.22% 59
2020
Q4 		$19.8M Buy
+584,000
New +$16.8M 0.28% 57

Other funds holding ORIC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CG
Column Group San Francisco, California $88.1M AUM 148.03% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RA Capital Management's ORIC Position: Q3 2021 in Review

RA Capital Management sold out of Oric Pharmaceuticals (ORIC) in Q3 2021, closing a stake of 584,000 shares — an estimated $10.3M sold.

RA Capital Management first reported a position in ORIC in Q4 2020 and held it in 3 quarters. The position peaked at $19.8M in Q4 2020. 82 funds tracked by Wall St. Rank hold ORIC as of Q3 2021.

  • RA Capital Management reported no remaining Oric Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • RA Capital Management sold 584,000 Oric Pharmaceuticals shares in Q3 2021, an estimated $10.3M.
  • RA Capital Management first reported a position in Oric Pharmaceuticals in Q4 2020 and held it in 3 quarters.
  • RA Capital Management's Oric Pharmaceuticals position peaked at $19.8M in Q4 2020.
  • 82 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q3 2021.

Based on RA Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.